Allianz Asset Management GmbH Sells 5,654 Shares of Balchem Corporation (NASDAQ:BCPC)

Allianz Asset Management GmbH reduced its holdings in Balchem Corporation (NASDAQ:BCPC - Free Report) by 15.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,803 shares of the basic materials company's stock after selling 5,654 shares during the quarter. Allianz Asset Management GmbH owned 0.09% of Balchem worth $5,113,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Covestor Ltd increased its holdings in shares of Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after acquiring an additional 76 shares in the last quarter. Federated Hermes Inc. bought a new position in shares of Balchem during the fourth quarter worth about $33,000. Versant Capital Management Inc grew its holdings in shares of Balchem by 534.2% during the first quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock worth $40,000 after buying an additional 203 shares in the last quarter. CWM LLC grew its holdings in shares of Balchem by 34.0% during the first quarter. CWM LLC now owns 520 shares of the basic materials company's stock worth $86,000 after buying an additional 132 shares in the last quarter. Finally, Huntington National Bank grew its holdings in shares of Balchem by 30.9% during the fourth quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock worth $108,000 after buying an additional 156 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Wall Street Zen cut Balchem from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. HC Wainwright set a $180.00 price target on Balchem and gave the stock a "buy" rating in a report on Monday, April 28th.

Balchem Trading Down 0.7%

Shares of BCPC stock traded down $1.08 during mid-day trading on Friday, reaching $151.40. 54,160 shares of the stock traded hands, compared to its average volume of 166,538. The stock's fifty day simple moving average is $160.29 and its two-hundred day simple moving average is $162.26. Balchem Corporation has a 1-year low of $145.70 and a 1-year high of $185.96. The company has a market cap of $4.94 billion, a price-to-earnings ratio of 36.29, a price-to-earnings-growth ratio of 3.28 and a beta of 0.89. The company has a quick ratio of 1.40, a current ratio of 2.44 and a debt-to-equity ratio of 0.18.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The basic materials company reported $1.27 EPS for the quarter, beating analysts' consensus estimates of $1.25 by $0.02. The firm had revenue of $255.47 million for the quarter, compared to analyst estimates of $250.31 million. Balchem had a return on equity of 12.01% and a net margin of 14.16%. The business's revenue for the quarter was up 9.1% on a year-over-year basis. During the same period last year, the firm posted $1.09 earnings per share. On average, research analysts anticipate that Balchem Corporation will post 4.64 EPS for the current fiscal year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.